Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape
…, D Weinberger, J Wildenbeest… - The Lancet Infectious …, 2023 - thelancet.com
Respiratory syncytial virus is the second most common cause of infant mortality and a major
cause of morbidity and mortality in older adults (aged >60 years). Efforts to develop a …
cause of morbidity and mortality in older adults (aged >60 years). Efforts to develop a …
The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study
JG Wildenbeest, MN Billard, RP Zuurbier… - The Lancet …, 2023 - thelancet.com
Background Respiratory syncytial virus (RSV) is a major cause of hospitalisation in infants.
The burden of RSV infection in healthy term infants has not yet been established. Accurate …
The burden of RSV infection in healthy term infants has not yet been established. Accurate …
Respiratory syncytial virus prevention and asthma in healthy preterm infants: a randomised controlled trial
…, NI Mazur, JG Wildenbeest… - The Lancet …, 2018 - thelancet.com
Background Respiratory syncytial virus (RSV) infection is associated with subsequent wheeze
and asthma. We previously reported on the causal relationship between prevention of …
and asthma. We previously reported on the causal relationship between prevention of …
Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort study
…, T Verheij, L Bont, J Wildenbeest - European …, 2021 - Eur Respiratory Soc
Background Respiratory syncytial virus (RSV) infection in older adults is recognised as an
important health issue. We aimed to assess the community burden of RSV in Europe in older …
important health issue. We aimed to assess the community burden of RSV in Europe in older …
Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in Europe
…, X Li, A Dacosta-Urbieta, MN Billard, J Wildenbeest… - Vaccine, 2023 - Elsevier
Background Respiratory syncytial virus (RSV) causes a considerable disease burden in young
children globally, but reliable estimates of RSV-related costs and health-related quality-of-…
children globally, but reliable estimates of RSV-related costs and health-related quality-of-…
International changes in respiratory syncytial virus (RSV) epidemiology during the COVID‐19 pandemic: association with school closures
…, LJ Bont, JG Wildenbeest - Influenza and other …, 2022 - Wiley Online Library
Background Little RSV activity was observed during the first expected RSV season since the
COVID‐19 pandemic. Multiple countries later experienced out‐of‐season RSV resurgences…
COVID‐19 pandemic. Multiple countries later experienced out‐of‐season RSV resurgences…
Specific cell tropism and neutralization of human parechovirus types 1 and 3: implications for pathogenesis and therapy development
…, G Koen, JG Wildenbeest… - Journal of general …, 2012 - microbiologyresearch.org
Human parechoviruses (HPeVs) are picornaviruses frequently infecting humans. While
HPeV1 is associated with mild disease, HPeV3 is the cause of neonatal sepsis and meningitis. …
HPeV1 is associated with mild disease, HPeV3 is the cause of neonatal sepsis and meningitis. …
Economic burden and health-related quality of life of respiratory syncytial virus and influenza infection in European community-dwelling older adults
Background Respiratory syncytial virus (RSV) and influenza virus infections result in a
considerable mortality and morbidity among the aging population globally. Influenza vaccination …
considerable mortality and morbidity among the aging population globally. Influenza vaccination …
T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults
…, CC Butler, SB Drysdale, JG Wildenbeest… - Frontiers in …, 2023 - frontiersin.org
Introduction The immune mechanisms supporting partial protection from reinfection and
disease by the respiratory syncytial virus (RSV) have not been fully characterized. In older adults…
disease by the respiratory syncytial virus (RSV) have not been fully characterized. In older adults…
Successful IVIG treatment of human parechovirus-associated dilated cardiomyopathy in an infant
JG Wildenbeest, KC Wolthers, B Straver, D Pajkrt - Pediatrics, 2013 - publications.aap.org
Human parechoviruses (HPeVs) are closely related to human enteroviruses and exhibit many
similarities in disease spectrum and symptoms. HPeV1 is most commonly associated with …
similarities in disease spectrum and symptoms. HPeV1 is most commonly associated with …
